Actinium Pharmaceuticals, Inc. (ATNM)
1.12
+0.01
(+0.90%)
USD |
NYAM |
Mar 16, 16:00
1.12
0.00 (0.00%)
After-Hours: 20:00
Actinium Pharmaceuticals EPS Diluted (Quarterly) : -0.1645 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 1.612 |
| Altimmune, Inc. | -0.2719 |
| Aldeyra Therapeutics, Inc. | -0.1074 |
| Avanos Medical, Inc. | -0.028 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.131M |
| Revenue (Quarterly) | 0.09M |
| Total Expenses (Quarterly) | 5.221M |
| Enterprise Value | -17.62M |
| Gross Profit Margin (Quarterly) | -128.9% |
| Profit Margin (Quarterly) | -5.70K% |
| Earnings Yield | -99.03% |
| Normalized Earnings Yield | -99.03 |